Ganglioneuroblastoma Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

14Recruiting trials

🩺

28Specialists

Regulatory Watchboard

10 events

Jun 2026Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Children's Oncology Group — PHASE2

TrialNOT YET RECRUITING

May 2026Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

National Cancer Institute (NCI) — PHASE1, PHASE2

TrialNOT YET RECRUITING

Mar 2026Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

Beijing Biotech — PHASE1, PHASE2

TrialRECRUITING

Nov 2025Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma

Federal Research Institute of Pediatric Hematology, Oncology and Immunology — PHASE3

TrialRECRUITING

Oct 2025Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

Assistance Publique - Hôpitaux de Paris

TrialNOT YET RECRUITING

Apr 2024Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

National Cancer Institute (NCI) — PHASE3

TrialRECRUITING

Nov 2023SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

Institut Curie — NA

TrialRECRUITING

Oct 2023Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

TrialRECRUITING

Sep 2023Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma

Federal Research Institute of Pediatric Hematology, Oncology and Immunology — PHASE3

TrialRECRUITING

Dec 2020Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

Children's Oncology Group — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Ganglioneuroblastoma.
Check the disease page for updates →

Clinical Trial Landscape

14 active trials

5Phase 3

2Phase 2

1Phase 1

2N/A

2Unknown

1PHASE1, PHASE2

1EARLY_PHASE1

14Total recruiting

Search clinical trials for Ganglioneuroblastoma →

Recent News & Research

No recent news articles indexed yet for Ganglioneuroblastoma.
Search PubMed for Ganglioneuroblastoma →

Browse all Ganglioneuroblastoma news →

Specialist Network

Top 6 by expertise

Holly J Meany

Children's Oncology Group

📍 Birmingham, Alabama

Score 111 trial

Kieuhoa T Vo

Children's Oncology Group

📍 Birmingham, Alabama

Score 82 trials1 pub

Rajen Mody, MB BS

Children's Oncology Group

📍 ANN ARBOR, MI

Score 62 trials

Catherine Albert, MD

Seattle Children's Hospital

Score 43 trials

Mary Meaghan P Granger

Children's Oncology Group

📍 SOUTHFIELD, MI

Score 01 trial

Tanya C Watt, M.D

Pediatric Early Phase Clinical Trial Network

📍 DALLAS, TX

Score 01 trial

View all Ganglioneuroblastoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰